High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model

Justin R Lenhard, Nicholas M. Smith, Zackery P. Bulman, Xun Tao, Visanu Thamlikitkul, Beom Soo Shin, Roger L Nation, Jian Li, Jurgen B Bulitta, Brian T Tsuji

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

Acinetobacter baumannii is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 108 CFU/ml of two clinical A. baumannii isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 14-day hollow-fiber infection model, high-dose ampicillin-sulbactam (8/4 g every 8 h, respectively) in combination with meropenem (2 g every 8 h) and polymyxin B (1.43 mg/kg of body weight every 12 h with loading dose) resulted in rapid (96 h) eradication of A. baumannii.

Original languageEnglish
Article numbere01268
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume61
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

Keywords

  • Acinetobacter
  • Antibiotic resistance
  • Antimicrobial combinations
  • Meropenem
  • Polymyxins
  • Sulbactam
  • Synergism

Cite this

Lenhard, Justin R ; Smith, Nicholas M. ; Bulman, Zackery P. ; Tao, Xun ; Thamlikitkul, Visanu ; Shin, Beom Soo ; Nation, Roger L ; Li, Jian ; Bulitta, Jurgen B ; Tsuji, Brian T. / High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model. In: Antimicrobial Agents and Chemotherapy. 2017 ; Vol. 61, No. 3.
@article{a057c74650874bc295f1d8bd4db2015a,
title = "High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model",
abstract = "Acinetobacter baumannii is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 108 CFU/ml of two clinical A. baumannii isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 14-day hollow-fiber infection model, high-dose ampicillin-sulbactam (8/4 g every 8 h, respectively) in combination with meropenem (2 g every 8 h) and polymyxin B (1.43 mg/kg of body weight every 12 h with loading dose) resulted in rapid (96 h) eradication of A. baumannii.",
keywords = "Acinetobacter, Antibiotic resistance, Antimicrobial combinations, Meropenem, Polymyxins, Sulbactam, Synergism",
author = "Lenhard, {Justin R} and Smith, {Nicholas M.} and Bulman, {Zackery P.} and Xun Tao and Visanu Thamlikitkul and Shin, {Beom Soo} and Nation, {Roger L} and Jian Li and Bulitta, {Jurgen B} and Tsuji, {Brian T}",
year = "2017",
month = "3",
day = "1",
doi = "10.1128/AAC.01268-16",
language = "English",
volume = "61",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "1098-6596",
publisher = "American Society for Microbiology",
number = "3",

}

High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model. / Lenhard, Justin R; Smith, Nicholas M.; Bulman, Zackery P.; Tao, Xun; Thamlikitkul, Visanu; Shin, Beom Soo; Nation, Roger L; Li, Jian; Bulitta, Jurgen B; Tsuji, Brian T.

In: Antimicrobial Agents and Chemotherapy, Vol. 61, No. 3, e01268, 01.03.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model

AU - Lenhard, Justin R

AU - Smith, Nicholas M.

AU - Bulman, Zackery P.

AU - Tao, Xun

AU - Thamlikitkul, Visanu

AU - Shin, Beom Soo

AU - Nation, Roger L

AU - Li, Jian

AU - Bulitta, Jurgen B

AU - Tsuji, Brian T

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Acinetobacter baumannii is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 108 CFU/ml of two clinical A. baumannii isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 14-day hollow-fiber infection model, high-dose ampicillin-sulbactam (8/4 g every 8 h, respectively) in combination with meropenem (2 g every 8 h) and polymyxin B (1.43 mg/kg of body weight every 12 h with loading dose) resulted in rapid (96 h) eradication of A. baumannii.

AB - Acinetobacter baumannii is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 108 CFU/ml of two clinical A. baumannii isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 14-day hollow-fiber infection model, high-dose ampicillin-sulbactam (8/4 g every 8 h, respectively) in combination with meropenem (2 g every 8 h) and polymyxin B (1.43 mg/kg of body weight every 12 h with loading dose) resulted in rapid (96 h) eradication of A. baumannii.

KW - Acinetobacter

KW - Antibiotic resistance

KW - Antimicrobial combinations

KW - Meropenem

KW - Polymyxins

KW - Sulbactam

KW - Synergism

UR - http://www.scopus.com/inward/record.url?scp=85014072479&partnerID=8YFLogxK

U2 - 10.1128/AAC.01268-16

DO - 10.1128/AAC.01268-16

M3 - Article

VL - 61

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 1098-6596

IS - 3

M1 - e01268

ER -